tiprankstipranks
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF
US Market
INNMF
Amplia Therapeutics
RESEARCH TOOLSreports
Want to see INNMF full AI Analyst Report?

Amplia Therapeutics (INNMF) Income Statement

19 Followers

Amplia Therapeutics Income Statement

Last quarter (Q2 2026), Amplia Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Amplia Therapeutics's net income was AU$-4.18M. See Amplia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
AU$ 3.78MAU$ 4.45MAU$ 1.19MAU$ 1.98MAU$ 1.53M
Gross Profit
AU$ 3.57MAU$ 4.01MAU$ 1.12MAU$ 1.98MAU$ 1.53M
Operating Expenses
AU$ 10.09MAU$ 8.44MAU$ 7.40MAU$ 5.62MAU$ 3.87M
Depreciation and Amortization
AU$ 9.96KAU$ 86.15KAU$ 73.37KAU$ 3.21K-
EBITDA
AU$ -6.78MAU$ -4.48MAU$ -7.26MAU$ -3.64MAU$ -3.81M
Operating Income
AU$ -6.52MAU$ -4.42MAU$ -7.48MAU$ -3.64MAU$ -3.88M
Other Income/Expenses
AU$ -55.88KAU$ -4.52MAU$ 84.46KAU$ -1.15KAU$ 60.40K
Pretax Income
AU$ -6.57MAU$ -8.94MAU$ -7.39MAU$ -3.64MAU$ -3.81M
Net Income
AU$ -6.57MAU$ -4.50MAU$ -6.24MAU$ -3.64MAU$ -2.28M
Per Share Metrics
Basic EPS
AU$ -0.02AU$ -0.02AU$ -0.03AU$ -0.02AU$ -0.02
Diluted EPS
AU$ -0.02AU$ -0.02AU$ -0.03AU$ -0.02AU$ -0.02
Weighted Average Shares Outstanding
 307.10M 194.01M 193.98M 145.55M 95.70M
Weighted Average Shares Outstanding (Diluted)
 307.21M 194.01M 193.98M 145.55M 95.70M
Currency in AUD

Amplia Therapeutics Earnings and Revenue History